Vertex Pharmaceuticals Inc (VRTX)
397.27
+0.63
(+0.16%)
USD |
NASDAQ |
Dec 20, 16:00
395.00
-2.27
(-0.57%)
After-Hours: 20:00
Vertex Pharmaceuticals Profit Margin (Quarterly): 37.71% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Gilead Sciences Inc | 16.61% |
| Bristol-Myers Squibb Co | 10.18% |
| Pfizer Inc | 25.22% |
| PTC Therapeutics Inc | -54.20% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.89% |
| Return on Assets | -2.17% |
| Return on Invested Capital | -2.89% |
| Gross Profit Margin (Quarterly) | 85.84% |
| Operating Margin (Quarterly) | 40.82% |
| Return on Net Operating Assets | -7.71% |